An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Ustekinumab
Related studies linked through entity extraction aliases.
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
USTekinumab in Fistulising Perianal Crohn's Disease (USTAP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis
- Status
- TERMINATED
- Phase
- PHASE3
Loss of RESponse to Ustekinumab Treated by Dose Escalation
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Ustekinumab in Bullous Pemphigoid
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Stelara fOr ChRonic AntibioTic rEfractory pouchitiS
- Status
- COMPLETED
- Phase
- PHASE3
Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)
- Status
- COMPLETED
- Phase
- N/A
Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)
- Status
- COMPLETED
- Phase
- PHASE2
Identification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease
- Status
- WITHDRAWN
- Phase
- NA
Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions
- Status
- COMPLETED
- Phase
- PHASE4
Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
- Status
- COMPLETED
- Phase
- N/A
Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease
- Status
- COMPLETED
- Phase
- N/A
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3